agilon health inc
NYSE:AGL

Watchlist Manager
agilon health inc Logo
agilon health inc
NYSE:AGL
Watchlist
Price: 0.6594 USD -5.6% Market Closed
Market Cap: $273.4m

agilon health inc
Investor Relations

Agilon Health, Inc. has developed a purpose-built model for providing the necessary capabilities, capital, and business models for existing physician groups to create a Medicare-centric, globally capitated line of business. The company is headquartered in Austin, Texas and currently employs 648 full-time employees. The company went IPO on 2021-04-15. The company enables primary care physicians (PCPs) to be agents in the communities they serve. The company offers healthcare for seniors across communities throughout the United States. The company has created an agilon Platform, which is a Total Care Model for community-based physicians. Its platform is delivered to its anchor physician groups through a long-term partnership model. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners attributed patients (global capitation arrangements). Its community-based physician groups are built around three elements, such as agilon's platform, agilon's long-term physician partnership approach and agilon's network. Its platform, partnership and network model enable its physician partners to be the quarterback for healthcare delivery in their communities.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 25, 2026
AI Summary
Q4 2025

Financial Turnaround: agilon health expects a strong improvement in profitability for 2026, with medical margin guidance of $300–$350 million and adjusted EBITDA expected to be breakeven at the midpoint.

Disciplined Contracting: The company exited unprofitable payer contracts, reduced exposure to Medicare Part D, and focused on economic sustainability, leading to lower overall membership but a higher percentage of premium and quality incentives.

Cost Trends: 2025 medical cost trends rose to 6.5% due to elevated inpatient costs in the third and fourth quarters. For 2026, a gross cost trend of 7.5% and net 7% is assumed, reflecting ongoing elevated expenses.

Operating Cost Cuts: agilon achieved $35 million in annual operating cost reductions, exceeding previous targets, and is actively seeking further savings through automation and technology.

Quality Initiatives: The company improved quality scores to 4.2 stars in 2024, expects to do better for 2025, and sees potential to more than double quality incentive contributions in 2026.

2026 Guidance: Revenue expected between $5.41–$5.58 billion, membership of 525,000–540,000, and a year-end cash position of at least $125 million.

Regulatory Risk: Management views the CMS advanced rate notice as inadequate but expects its clinical programs to mitigate most risk model changes and sees minimal exposure to unlinked or audio-only coding.

Key Financials
Medicare Advantage Membership
511,000
ACO REACH Membership
114,000
Total Revenue (Q4 2025)
$1.57B
Total Revenue (Full Year 2025)
$5.93B
Medical Margin (Q4 2025)
-$74M
Medical Margin (Full Year 2025)
-$57M
Medical Cost Trend (2025)
6.5%
Adjusted EBITDA (Q4 2025)
-$142M
Adjusted EBITDA (Full Year 2025)
-$296M
ACO REACH Adjusted EBITDA (Q4 2025)
-$6M
ACO REACH Adjusted EBITDA (Full Year 2025)
$41M
Operating Cost Reductions Achieved
$35M
Cash and Marketable Securities (Year End 2025)
$285M
General & Administrative Expense (2026 Guidance)
$234M
Geography Entry Expense (2026 Guidance)
$15M
Quality Score (2024, Composite)
4.2 stars
Other Earnings Calls

Management

Mr. Steven Jackson Sell
President, CEO & Director
No Bio Available
Mr. Jeffrey Alan Schwaneke CPA
Executive VP & CFO
No Bio Available
Mr. Girish Venkatachaliah
Chief Technology Officer
No Bio Available
Mr. Benjamin Shaker
Chief Markets Officer
No Bio Available
Mr. Timothy Gertsch
VP, Controller & Chief Accounting Officer
No Bio Available
Leland Thomas
Senior Manager of Investor Relations
No Bio Available
Ms. Denise Zamore
Chief Legal Officer & Secretary
No Bio Available
Ms. Claire Mulhearn
Chief Communications & Public Affairs Officer
No Bio Available
Mr. Mat Varghese
Chief People Officer
No Bio Available
Mr. Bill Farry
Chief of Technology Innovation
No Bio Available

Contacts

Address
TEXAS
Austin
6210 E Hwy 290, Suite 450
Contacts
+15622563800.0
www.agilonhealth.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett